Occhieppo, V. B., Basmadjian, O. M., Marchese, N. A., Jaime, A. d. V., Perez, M. F., Baiardi, G. C., & Bregonzio Diaz, C. (2023). Schizophrenia-like endurable behavioral and neuroadaptive changes induced by ketamine administration involve Angiotensin II AT1 receptor. Web
Citación estilo ChicagoOcchieppo, Victoria Belen, Osvaldo Martin Basmadjian, Natalia Andrea Marchese, Andrea del Valle Jaime, Mariela Fernanda Perez, Gustavo Carlos Baiardi, and Claudia Bregonzio Diaz. Schizophrenia-like Endurable Behavioral and Neuroadaptive Changes Induced By Ketamine Administration Involve Angiotensin II AT1 Receptor. 2023.
Cita MLAOcchieppo, Victoria Belen, et al. Schizophrenia-like Endurable Behavioral and Neuroadaptive Changes Induced By Ketamine Administration Involve Angiotensin II AT1 Receptor. 2023.